Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
Zhenfeng Zhang(Columbia University Irving Medical Center), Jae Cheol Lee(Asan Medical Center), Luping Lin(University of California, San Francisco), Victor Olivas(University of California, San Francisco), Valerie Au(Columbia University Irving Medical Center), Thomas LaFramboise(University Hospitals Cleveland Medical Center), Mohamed Abdel-Rahman(University Hospitals Cleveland Medical Center), Xiaoqi Wang(Columbia University Irving Medical Center), Alan D. Levine(University Hospitals Cleveland Medical Center), Jin Kyung Rho(Asan Medical Center), Yun Jung Choi(Asan Medical Center), Chang‐Min Choi(Asan Medical Center), Sang-We Kim(Asan Medical Center), Se Jin Jang(Asan Medical Center), Young Soo Park(Asan Medical Center), Woo Sung Kim(Asan Medical Center), Dae Ho Lee(Asan Medical Center), Jung‐Shin Lee(Asan Medical Center), Vincent A. Miller(Memorial Sloan Kettering Cancer Center), Maria E. Arcila(Memorial Sloan Kettering Cancer Center), Marc Ladanyi(Memorial Sloan Kettering Cancer Center), Philicia Moonsamy(Memorial Sloan Kettering Cancer Center), Charles L. Sawyers(Memorial Sloan Kettering Cancer Center), Titus J. Boggon(Yale University), C. Patrick(Cleveland Clinic Lerner College of Medicine), Carlota Costa(Institut Català d'Oncologia), Miquel Tarón(Institut Català d'Oncologia), Rafael Rosell(Institut Català d'Oncologia), Balázs Halmos(Columbia University Irving Medical Center), Trever G. Bivona(Memorial Sloan Kettering Cancer Center)
Cited by 1,217
Abstract
Related Papers
No related papers found
Powered by citation graph analysis